PMID- 33079325 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201023 IS - 2363-9024 (Electronic) IS - 2363-9024 (Linking) VI - 6 IP - 1 DP - 2020 Oct 20 TI - Qualitative measurement of opioid effects on pain and dyspnea: gender difference in the sensitivity. PG - 85 LID - 10.1186/s40981-020-00391-y [doi] LID - 85 AB - BACKGROUND: An increasing number of patients come to the operating room in use of opioid analgesics. They have different levels of tolerance to opioid effects which challenge the anesthesiologists in search of safe and effective opioid dosing perioperatively. The tested hypothesis is that simple measures introduced will allow us to measure tolerance qualitatively. Opioid effects on pain (analgesia) and dyspnea sensations (relieving effect) are tested. Patients were allocated to three groups according to pre-operative analgesics: (1) control, without any opioid analgesics, (2) weak opioid, and (3) strong opioid. Pressure pain threshold (PPT) and no-respiratory sensation period (NRSP) were measured at two points: before and 3 min after intravenous fentanyl administration. RESULTS: A total of 58 (43 controls, 9 weak opioids, and 6 strong opioids) patients were enrolled. PPT and NRSP, after iv 2 mug/kg ideal body weight (IBW) fentanyl, were significantly elevated in the control patients (PPT: 6.2 +/- 2.1 N to 9.2 +/- 3.9 N, p < 0.0001, NRSP: 17.8 +/- 10.8 s to 22.8 +/- 18.7 s, p < 0.005, paired t test). However, preoperative opioid use, though with tendency, did not show a significant decrease of the opioid effect. Due to an insufficient number of participants, no conclusion could be drawn. Further analysis of the data from control patients showed a significant difference between the two sexes in sensitivity to PPT and NRSP, as well as fentanyl effect on PPT. CONCLUSIONS: Current data showed a simple method of measuring the opioid effect on two dimensions: pain and respiration. Though not able to show a qualitative measurement of tolerance formation in opioid-users, data from control patients showed females to be more sensitive to pain and dyspnea but is less sensitive to the opioid effect. Further studies are necessary to show whether these gender differences serve as clinical relevance. TRIAL REGISTRATION: UMIN, UMIN 000011580. Registered 27 August 2013, https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000013352&language=J. FAU - Nozaki-Taguchi, Natsuko AU - Nozaki-Taguchi N AUID- ORCID: 0000-0001-7855-6138 AD - Department of Anesthesiology, Chiba University Graduate School of Medicine, 1-8-1 Inohana Chuo, Chiba, 260-8670, Japan. nnoztag@faculty.chiba-u.jp. FAU - Hayashida, Taiichiro AU - Hayashida T AD - Department of Anesthesiology, Chiba University Graduate School of Medicine, 1-8-1 Inohana Chuo, Chiba, 260-8670, Japan. FAU - Isono, Shiroh AU - Isono S AD - Department of Anesthesiology, Chiba University Graduate School of Medicine, 1-8-1 Inohana Chuo, Chiba, 260-8670, Japan. LA - eng PT - Journal Article DEP - 20201020 PL - Germany TA - JA Clin Rep JT - JA clinical reports JID - 101682121 PMC - PMC7575662 OTO - NOTNLM OT - Analgesia OT - Dyspnea relieving effect OT - Experimental pain OT - Non-respiratory sensation period OT - Opioid COIS- The authors declare that they have no competing interests. EDAT- 2020/10/21 06:00 MHDA- 2020/10/21 06:01 PMCR- 2020/10/20 CRDT- 2020/10/20 12:13 PHST- 2020/09/14 00:00 [received] PHST- 2020/10/08 00:00 [accepted] PHST- 2020/10/05 00:00 [revised] PHST- 2020/10/20 12:13 [entrez] PHST- 2020/10/21 06:00 [pubmed] PHST- 2020/10/21 06:01 [medline] PHST- 2020/10/20 00:00 [pmc-release] AID - 10.1186/s40981-020-00391-y [pii] AID - 391 [pii] AID - 10.1186/s40981-020-00391-y [doi] PST - epublish SO - JA Clin Rep. 2020 Oct 20;6(1):85. doi: 10.1186/s40981-020-00391-y.